Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 22;13(1):8.
doi: 10.3390/biology13010008.

A Review on the Protective Effects of Probiotics against Alzheimer's Disease

Vibhuti Mishra  1 , Dhananjay Yadav  2 , Kavita Singh Solanki  3 , Bhupendra Koul  4 , Minseok Song  2
Affiliations
Review

A Review on the Protective Effects of Probiotics against Alzheimer's Disease

Vibhuti Mishra et al. Biology (Basel). .

Abstract

This review summarizes the protective effects of probiotics against Alzheimer's disease (AD), one of the most common neurodegenerative disorders affecting older adults. This disease is characterized by the deposition of tau and amyloid β peptide (Aβ) in different parts of the brain. Symptoms observed in patients with AD include struggles with writing, speech, memory, and knowledge. The gut microbiota reportedly plays an important role in brain functioning due to its bidirectional communication with the gut via the gut-brain axis. The emotional and cognitive centers in the brain are linked to the functions of the peripheral intestinal system via this gut-brain axis. Dysbiosis has been linked to neurodegenerative disorders, indicating the significance of gut homeostasis for proper brain function. Probiotics play an important role in protecting against the symptoms of AD as they restore gut-brain homeostasis to a great extent. This review summarizes the characteristics, status of gut-brain axis, and significance of gut microbiota in AD. Review and research articles related to the role of probiotics in the treatment of AD were searched in the PubMed database. Recent studies conducted using animal models were given preference. Recent clinical trials were searched for separately. Several studies conducted on animal and human models clearly explain the benefits of probiotics in improving cognition and memory in experimental subjects. Based on these studies, novel therapeutic approaches can be designed for the treatment of patients with AD.

Keywords: Alzheimer’s disease; dysbiosis; gut microbiome; gut–brain axis; neurodegeneration; neurodegenerative disorders; neurofibrillary tangles; probiotics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Pictorial representation of the components of gut–brain axis affected by dysregulated gut microbiota that results in AD.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Valdes A.M., Walter J., Segal E., Spector T.D. Role of the gut microbiota in nutrition and health. BMJ. 2018;361:k2179. doi: 10.1136/bmj.k2179. - DOI - PMC - PubMed
    1. Ajayi A., Jolaiya T., Smith S. Evolving technologies in gastrointestinal microbiome era and their potential clinical applications. J. Clin. Med. 2020;9:2565. doi: 10.3390/jcm9082565. - DOI - PMC - PubMed
    1. Gevers D., Pop M., Schloss P.D., Huttenhower C. Bioinformatics for the human microbiome project. PLoS Comput. Biol. 2012;8:e1002779. doi: 10.1371/journal.pcbi.1002779. - DOI - PMC - PubMed
    1. Ehrlich S.D., Consortium M. MetaHIT: The European Union Project on metagenomics of the human intestinal tract. In: Nelson K., editor. Metagenomics of the Human Body. Springer; New York, NY, USA: 2011. - DOI
    1. Kho Z.Y., Lal S.K. The Human Gut Microbiome—A Potential Controller of Wellness and Disease. Front. Microbiol. 2018;9:1835. doi: 10.3389/fmicb.2018.01835. - DOI - PMC - PubMed

LinkOut - more resources